Jonathan Allan

GENERAL COUNSEL & CORP SEC

GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc., filing insider transactions between 2026-06-16 and 2026-10-02.

Total Purchases

—

0 transactions

Total Sales

$152K

4 transactions

Companies Traded

4 total filings

Active Since

2026-06-16

Last: 2026-10-02

Companies

Stoke Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-10-02	STOK	Sale	627	$26.33	$17K	20.6K	SEC ↗
2026-08-18	STOK	Sale	145	$32.47	$5K	21.2K	SEC ↗
2026-08-18	STOK	Sale	2,716	$32.01	$87K	21.4K